Barriers and Facilitators of HPV Vaccination in the VFC Program (original) (raw)
HPV vaccination bridges to HPV screening
Sherri Gorin
EClinicalMedicine, 2020
View PDFchevron_right
Increased production and comprehensive guidelines needed for HPV vaccine
Kul Gautam
The Lancet, 2020
View PDFchevron_right
HPV prophylactic vaccines: Second-generation or first-generation vaccines
Golnaz Mardani
Journal of Solid Tumors, 2015
View PDFchevron_right
Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer
Jennifer S. Smith
2008
View PDFchevron_right
Post-licensure monitoring of HPV vaccine in the United States
Elizabeth Unger
Vaccine, 2010
View PDFchevron_right
Quality Improvement Project on OB/GYN Ambulatory Clinic HPV Vaccination at Lincoln Medical and Mental Health Center
Andres Molina
Journal of Pediatric and Adolescent Gynecology, 2015
View PDFchevron_right
HPV vaccination: Pilot study assessing characteristics of high and low performing primary care offices
Martin Mahoney
Preventive Medicine Reports, 2018
View PDFchevron_right
Human Papillomavirus Vaccination for the Prevention of Cervical and Other Related Cancers
F. Xavier Bosch
Statistics in the health sciences, 2012
View PDFchevron_right
Population Impact of HPV Vaccines: Summary of Early Evidence
Elizabeth Unger
Journal of Adolescent Health, 2013
View PDFchevron_right
Quality measurement and benchmarking of HPV vaccination services
MariaSole Benigni
Human Vaccines & Immunotherapeutics, 2013
View PDFchevron_right
Prevention of sexually transmitted infections among girls and young women in relation to their HPV vaccination status
Carla Xodo
The European Journal of Public Health, 2013
View PDFchevron_right
Challenges and opportunities of school-based HPV vaccination in Canada
Clara Rubincam
Human Vaccines & Immunotherapeutics
View PDFchevron_right
Urban and Rural Safety Net Health Care System Clinics: No Disparity in HPV4 Vaccine Completion Rates
Gerard Malnar
PLoS ONE, 2014
View PDFchevron_right
Cervical Cancer and Ethical issues in HPV Vaccination
Sadia A . Sony
Bangladesh Journal of Bioethics, 2017
View PDFchevron_right
Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage
Oliver Nahkur
Vaccine, 2017
View PDFchevron_right
Global challenges of implementing human papillomavirus vaccines
Janice Graham
International Journal for Equity in Health, 2011
View PDFchevron_right
Gender neutral HPV vaccination programs: Reconsidering policies to expand cancer prevention globally
Andrew Dykens
Frontiers in Public Health, 2023
View PDFchevron_right
Current Status of Human Papillomavirus Vaccines
Dr.Rajesh K Bhaskar
Journal of the Formosan Medical Association, 2010
View PDFchevron_right
Summary of the NACI Update on the recommended use of Human Papillomavirus (HPV) vaccine: Nine-valent HPV vaccine two-dose immunization schedule and the use of HPV vaccines in immunocompromised populations
Shainoor J Ismail
Canada Communicable Disease Report, 2017
View PDFchevron_right
Guidance for the introduction of HPV vaccines in EU countries
Pier Luigi Lopalco
View PDFchevron_right
HPV Type-Specific Prevalence a Decade after the Implementation of the Vaccination Program: Results from a Pilot Study
Iolanda Grappasonni
Vaccines, 2021
View PDFchevron_right
Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012
Elizabeth Unger
Vaccine, 2015
View PDFchevron_right
Using risk to target HPV vaccines in high-risk, low-resource organizations
Carolyn Sampselle
Human Vaccines & Immunotherapeutics, 2013
View PDFchevron_right
Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts
F. Xavier Bosch
Vaccine, 2006
View PDFchevron_right
One in Four California Adolescent Girls Have Had Human Papillomavirus Vaccination
Nancy Breen
Ucla Center For Health Policy Research, 2009
View PDFchevron_right
Modifiable influences on female HPV vaccine uptake at the clinic encounter level: A literature review
Carolyn Sampselle
Journal of the American Association of Nurse Practitioners, 2014
View PDFchevron_right
Public Awareness about Cancer Cervix and Human Papilloma Virus Vaccines
Dr.Smriti Gupta
The Journal of South Asian Federation of Menopause Societies, 2015
View PDFchevron_right
Implementation of HPV vaccination guidelines in a diverse population in Los Angeles: Results from an environmental scan of local HPV resources and needs
Kathleen Sanchez
Vaccine, 2017
View PDFchevron_right
An Assessment of the Readiness for Introduction of the HPV Vaccine in Uganda
Anne Katahoire
2008
View PDFchevron_right
Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
Robert Kurman
JNCI Journal of the National Cancer Institute, 2010
View PDFchevron_right
Introduction of HPV vaccination in Kenya
Heleen Vermandere
AVRUG-bulletin, 2016
View PDFchevron_right
Sound implementation of human papillomavirus vaccination as a community-randomized trial
Jorma Paavonen
Therapy, 2008
View PDFchevron_right
Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males
Gemma Villanueva
Cochrane Database of Systematic Reviews, 2019
View PDFchevron_right
The influence of free quadrivalent human papillomavirus vaccine (HPV4) on the timely completion of the three dose series
Gerard Malnar
Preventive Medicine, 2014
View PDFchevron_right
Vaccines for human papillomavirus infection: A critical analysis
Devinder Thappa
Indian Journal of Dermatology, Venereology and Leprology, 2009
View PDFchevron_right